Back

Increase in diagnoses associated with Post Acute Sequelae of COVID-19 (PASC) before and during the COVID-19 pandemic: a case-control study in the total population of Region Stockholm.

Lindberg, P.; Ljunggren, G.; Lee, S.; Kolosenko, I.; Runold, M.; Piontkovskaya, K.; Wachtler, C.; Wheelock, A. M.; Carlsson, A. C.

2024-06-08 primary care research
10.1101/2024.06.07.24308594 medRxiv
Show abstract

ObjectivesLong COVID, defined as diverse symptoms persisting >3 months post-infection, remains a major post-pandemic healthcare burden. Here we investigate risk factor posed by pre-existing respiratory symptoms and illnesses for development of long COVID, with focus on individuals with mild-to-moderate COVID-19 at the primary infection, that did not require hospitalization during the primary SARS-CoV-2 infection. MethodsThis case-control study was designed to investigate the prevalence of respiratory system-related diagnoses in adult, non-hospitalized long COVID patients (cases) compared to matched controls without a history of long COVID. Data was extracted from the Stockholm Regions database (VAL) and included diagnoses 12 months pre- and 6 months post-long COVID diagnosis as well as pre-pandemic diagnoses (year 2019). Adjusted logistic regression models were applied. ResultsPatients with Long COVID displayed higher frequencies of pre-pandemic respiratory conditions (year 2019) as well as 12 months before long COVID diagnosis compared to controls, including acute upper respiratory tract infections (men: Odds ratio (OR) 2.47, women: OR 2.22), asthma (men: OR 1.76, women: OR 1.95), and bronchitis (men: OR 2.15, women: OR 2.71). ORs for asthma were the highest 12 months before long COVID diagnosis (men: OR 4.18, women: OR 3.76). ConclusionPatients with Long COVID with a mild-to-moderate primary SARS-CoV-2 infection had higher prevalence of pre-existing respiratory conditions than controls, suggesting that respiratory diseases including asthma were a significant risk factor for long COVID also in the non-hospitalized population. Understanding the link between chronic respiratory illnesses and long COVID is vital for refining clinical strategies and improving outcomes in post-viral conditions. Key take-home messagePre-pandemic respiratory diagnoses, including asthma, as well as female sex represent significant risk factors for developing long COVID in individuals with a mild-to-moderate primary SARS-CoV-2 infection not requiring hositalization.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
ERJ Open Research
44 papers in training set
Top 0.1%
33.7%
2
BMJ Open Respiratory Research
32 papers in training set
Top 0.1%
10.3%
3
Pediatric Pulmonology
14 papers in training set
Top 0.1%
8.6%
50% of probability mass above
4
PLOS ONE
4510 papers in training set
Top 23%
7.3%
5
BMJ Open
554 papers in training set
Top 4%
5.0%
6
BMC Medicine
163 papers in training set
Top 2%
2.8%
7
eClinicalMedicine
55 papers in training set
Top 0.4%
1.9%
8
Journal of Infection
71 papers in training set
Top 1%
1.7%
9
Frontiers in Public Health
140 papers in training set
Top 5%
1.7%
10
The Lancet Digital Health
25 papers in training set
Top 0.5%
1.5%
11
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.5%
12
Thorax
32 papers in training set
Top 0.5%
1.5%
13
European Respiratory Journal
54 papers in training set
Top 1%
1.5%
14
BJGP Open
12 papers in training set
Top 0.4%
1.4%
15
International Journal of Environmental Research and Public Health
124 papers in training set
Top 5%
1.4%
16
Scientific Reports
3102 papers in training set
Top 70%
0.9%
17
International Journal of Epidemiology
74 papers in training set
Top 2%
0.8%
18
Wellcome Open Research
57 papers in training set
Top 2%
0.8%
19
Journal of Medical Internet Research
85 papers in training set
Top 4%
0.8%
20
Nutrients
64 papers in training set
Top 2%
0.7%
21
Frontiers in Medicine
113 papers in training set
Top 7%
0.7%
22
Archives of Clinical and Biomedical Research
28 papers in training set
Top 3%
0.7%
23
Emergency Medicine Journal
20 papers in training set
Top 0.7%
0.7%
24
BMJ Public Health
18 papers in training set
Top 1%
0.5%
25
Allergy
23 papers in training set
Top 0.9%
0.5%
26
Infectious Diseases
14 papers in training set
Top 0.3%
0.5%
27
Nicotine & Tobacco Research
11 papers in training set
Top 0.2%
0.5%